Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
Rhinology Journal · 2023
DOI: 10.4193/rhin22.116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Rhinology Journal, 2023. Verfasst von C Philpott und 14 weiteren Autor:innen. Beteiligte Einrichtung: James Paget University Hospital, Great Yarmouth, United Kingdom. Hauptthemen laut MEDLINE: Quality of Life, Olfaction Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Statement of problem: Evaluating the effectiveness of the management of Olfactory Dysfunction (OD) has been limited by a paucity of high-quality randomised and/or controlled trials. A major barrier is heterogeneity of outcomes in such studies. Core outcome sets (COS) –standardized sets of outcomes that should be measured/reported as determined by consensus—would help overcome this problem and facilitate future meta-analyses and/or systematic reviews (SRs). We set out to develop a COS for interventions for patients with OD.
Methods
A long-list of potential outcomes was identified by a steering group utilising a literature review, thematic analysis of a wide range of stakeholders’ views and systematic analysis of currently available Patient Reported Outcome Measures (PROMs). A subsequent e-Delphi process allowed patients and healthcare practitioners to individually rate the outcomes in terms of importance on a 9-point Likert scale.
Results
After 2 rounds of the iterative eDelphi process, the initial outcomes were distilled down to a final COS including subjective questions (visual analogue scores, quantitative and qualitative), quality of life measures, psychophysical testing of smell, baseline psychophysical testing of taste, and presence of side effects along with the investigational medicine/device and patient’s symptom log.
Conclusions
Inclusion of these core outcomes in future trials will increase the value of research on clinical interventions for OD. We include recommendations regarding the outcomes that should be measured, although future work will be required to further develop and revalidate existing outcome measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- James Paget University Hospital, Great Yarmouth, United Kingdom.
- Flavour Clinic, University Clinic for Flavour, Balance and Sleep, Department of Otorhinolaryngology, Regional Hospital Godstrup, Denmark.
- ENT University of Insubria, Italian Academy of Rhinology, Varese, Italy.
- Department of Biomedicine, Aarhus University, Denmark.
- Department of Anatomy, Universitat du Quebec a Trois-Rivieres, Canada.
- 2nd ORL Department, Aristotle University, Thessaloniki, Greece.
Zitieren
APA
Philpott, C., Kumaresan, K., Fjaeldstad, A. W., Macchi, A., Monti, G., Frasnelli, J., Konstantinidis, I., Pinto, J., Mullol, J., Boardman, J., Vodicka, J., Holbrook, E., Ramakrishnan, V. R., Lechner, M., & Hummel, T. (2023). Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative. Rhinology Journal. https://doi.org/10.4193/rhin22.116
Vancouver
Philpott C, Kumaresan K, Fjaeldstad AW, Macchi A, Monti G, Frasnelli J, et al. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative. Rhinology Journal. 2023. doi:10.4193/rhin22.116
BibTeX
@article{Philpott2023,
author = {Philpott, C and Kumaresan, K and Fjaeldstad, A W and Macchi, A and Monti, G and Frasnelli, J and Konstantinidis, I and Pinto, J and Mullol, J and Boardman, J and Vodicka, J and Holbrook, E and Ramakrishnan, V R and Lechner, M and Hummel, T},
title = {Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative},
journal = {Rhinology Journal},
year = {2023},
doi = {10.4193/rhin22.116}
}
EUVIMED